rs201354264

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_025132.4(WDR19):​c.3008A>G​(p.Glu1003Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000959 in 1,583,332 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00065 ( 0 hom., cov: 32)
Exomes š‘“: 0.00099 ( 10 hom. )

Consequence

WDR19
NM_025132.4 missense

Scores

4
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:7

Conservation

PhyloP100: 4.46
Variant links:
Genes affected
WDR19 (HGNC:18340): (WD repeat domain 19) The protein encoded by this gene is a member of the WD (tryptophan-aspartic acid) repeat family, which is a large family of structurally-related proteins known to participate in a wide range of cellular processes. Each WD repeat typically contains about 40 amino acids that are usually bracketed by glycine-histidine and tryptophan-aspartic acid (WD) dipeptides. This protein contains six WD repeats, three transmembrane domains, and a clathrin heavy-chain repeat. Mutations in this gene have been described in individuals with a wide range of disorders affecting function of the cilium. These disorders are known as ciliopathies, and include Jeune syndrome, Sensenbrenner syndromes, Senior-Loken syndrome, combined or isolated nephronophthisis (NPHP), and retinitis pigmentosa (RP). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009061396).
BP6
Variant 4-39255854-A-G is Benign according to our data. Variant chr4-39255854-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 437272.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=5, Uncertain_significance=2}. Variant chr4-39255854-A-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00065 (99/152306) while in subpopulation SAS AF= 0.0029 (14/4824). AF 95% confidence interval is 0.00175. There are 0 homozygotes in gnomad4. There are 44 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 10 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WDR19NM_025132.4 linkc.3008A>G p.Glu1003Gly missense_variant Exon 27 of 37 ENST00000399820.8 NP_079408.3 Q8NEZ3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WDR19ENST00000399820.8 linkc.3008A>G p.Glu1003Gly missense_variant Exon 27 of 37 1 NM_025132.4 ENSP00000382717.3 Q8NEZ3-1
WDR19ENST00000506869.5 linkn.*2589A>G non_coding_transcript_exon_variant Exon 26 of 36 2 ENSP00000424319.1 D6RBA0
WDR19ENST00000512095.5 linkn.2006A>G non_coding_transcript_exon_variant Exon 17 of 23 2
WDR19ENST00000506869.5 linkn.*2589A>G 3_prime_UTR_variant Exon 26 of 36 2 ENSP00000424319.1 D6RBA0

Frequencies

GnomAD3 genomes
AF:
0.000637
AC:
97
AN:
152188
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00249
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00100
Gnomad OTH
AF:
0.000956
GnomAD3 exomes
AF:
0.00117
AC:
260
AN:
222972
Hom.:
2
AF XY:
0.00143
AC XY:
172
AN XY:
120036
show subpopulations
Gnomad AFR exome
AF:
0.000215
Gnomad AMR exome
AF:
0.000566
Gnomad ASJ exome
AF:
0.000965
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00344
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00135
Gnomad OTH exome
AF:
0.00110
GnomAD4 exome
AF:
0.000992
AC:
1419
AN:
1431026
Hom.:
10
Cov.:
29
AF XY:
0.00110
AC XY:
783
AN XY:
709092
show subpopulations
Gnomad4 AFR exome
AF:
0.000152
Gnomad4 AMR exome
AF:
0.000609
Gnomad4 ASJ exome
AF:
0.000830
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00331
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000896
Gnomad4 OTH exome
AF:
0.00138
GnomAD4 genome
AF:
0.000650
AC:
99
AN:
152306
Hom.:
0
Cov.:
32
AF XY:
0.000591
AC XY:
44
AN XY:
74484
show subpopulations
Gnomad4 AFR
AF:
0.0000722
Gnomad4 AMR
AF:
0.000589
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00290
Gnomad4 FIN
AF:
0.0000941
Gnomad4 NFE
AF:
0.00100
Gnomad4 OTH
AF:
0.000946
Alfa
AF:
0.00120
Hom.:
1
Bravo
AF:
0.000691
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000612
AC:
5
ExAC
AF:
0.00128
AC:
154
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:7
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 17, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

May 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

WDR19: BS2 -

not specified Uncertain:1
Sep 14, 2016
Genetic Services Laboratory, University of Chicago
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Connective tissue disorder Uncertain:1
Apr 28, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Asphyxiating thoracic dystrophy 5;C3280612:Nephronophthisis 13;C3280616:Cranioectodermal dysplasia 4;C4225376:Senior-Loken syndrome 8;C5676980:Spermatogenic failure 72 Benign:1
Aug 20, 2020
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: research

- -

Asphyxiating thoracic dystrophy 5 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

WDR19-related disorder Benign:1
Feb 10, 2022
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Cranioectodermal dysplasia 4 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Asphyxiating thoracic dystrophy 5;C4225376:Senior-Loken syndrome 8 Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.20
T
Eigen
Benign
-0.25
Eigen_PC
Benign
-0.089
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Benign
0.72
T
M_CAP
Benign
0.062
D
MetaRNN
Benign
0.0091
T
MetaSVM
Benign
-0.78
T
MutationAssessor
Uncertain
2.2
M
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-1.7
N
REVEL
Benign
0.11
Sift
Benign
0.078
T
Sift4G
Benign
0.13
T
Polyphen
0.0050
B
Vest4
0.52
MVP
0.64
MPC
0.20
ClinPred
0.027
T
GERP RS
3.4
Varity_R
0.075
gMVP
0.30

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201354264; hg19: chr4-39257474; API